Certified by Founder Lodge
Mission BioCapital
United States - Cambridge, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $88,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mission BioCapital is a VC firm making pivotal early-stage investments in biotech companies. We support companies with lab space, capital, and strategic partners; idea to exit.
| Company | Date | Round | Raised |
|---|---|---|---|
QurAlis |
March, 10 ,2023 | Series B | $88,000,000 |
Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
Alessa Therapeutics, Inc. |
December, 13 ,2024 | Seed | $15,000,000 |
Sensorium Therapeutics |
September, 03 ,2025 | Series A | $25,000,000 |
QurAlis
Mediar Therapeutics
Nocion Therapeutics, Inc.
Integrated Biosciences, Inc.
Alessa Therapeutics, Inc.
Sensorium Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)